UK Markets closed

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.7900+0.2300 (+8.98%)
At close: 04:00PM EDT
2.8800 +0.09 (+3.23%)
After hours: 05:42PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • J
    Jens
    where is cramers BUY BUY BUY button?
  • B
    Bobby
    Company hired 14 new employees from latest inducement grant filings. This compared to 2-3 typically announced on these.

    Sounds like sales are ramping up in an accelerated manner, due mainly to hospital surgeries delayed from covid being undertaken, as well as uptick in Antibiotic resistant infections due to overuse of genetic treatment from covid Era.

    Not only do we hold an undervalued company, but one that is now experiencing accelerated sales growth. This earnings should wake the market up.
  • I
    IFTNorh
    Jeffies price targets 13+ analyst median price target $20/ share
  • I
    IFTNorh
    Weekly scrips avg 2m now bodes well.. estimated Revenue
    Report after the close today 28-32 milion
  • O
    Ooi
    What makes prtk attractive as compared to gamida and bluebio?
  • C
    Carmine
    Should have been up over 10% on those numbers .
  • j
    jos p
    They beat projected sales,
  • O
    Ooi
    Anyone can gv me a quick info..of how come prtk has such a high tp of 18.50 from yahoo finance although ER didnt hit its target? And wht is the catalyst contribute to ytrdy trade up 12%?
  • C
    Carmine
    Over 30 million this quarter.
  • O
    Ooi
    Why drop after huge up the day bfr...any bad news?
  • C
    Carmine
    Ed Arce gives a $20 price target,God has spoken.
  • C
    Carmine
    Expect big numbers coming in the next earnings report,breaking records every week in sales.
  • O
    Old Man Logan
    Like Jens said, this is one biotech stock I DON'T want to see get a buyout soon. Why? Average analyst target price is 18.50... no buyer is going to offer more than 6 today... we need time to let the thesis play out.. THEN, get bought out a couple years from now at 30+
  • B
    Bobby
    The buyout of $LJPC for $143mil EV, would translate to a $65mil upside to $PRTK if we are comparing Price/Sales. That's using historical numbers. Not even taking into account $PRTK is growing revenue at a much faster rate than $LJPC. Also not factoring in that $PRTK's Nuzyra has blockbuster drug status pretty much written in the cards. Bottom line, this stock should be up at minimum $1.20 ($3.80 SP) just in today's news. Antibiotics sector may finally be getting the recognition it deserves.
  • O
    Ooi
    Prtk looks downtrend weekly unless its low stay above 2.63 and its high break 2.93...fundamentally wht s powerful of prtk till yahoo finance gv such a high target price?!
  • C
    Carmine
    Wonder if China is stock piling nuyzra,zlab reports tomorrow?
  • C
    Carmine
    Biggest volume day in a while,too bad it was to the downside,maybe someone didn’t like managements selling their free shares.
  • J
    John
    Tuesday the 5th we will break thru the 20 and 50 day. looking for 2.10 close tommorrow
  • v
    vij
    Why prtk going down?
  • O
    Ooi
    So volatile...